Presentations | Sutro Biopharma, Inc.

STRO-001 – Publication Highlights

STRO-001 – Publication Highlights Pan Pacific Lymphoma, 2018 HIGH FREQUENCY OF CD74 EXPRESSION IN B-CELL NON-HODGKIN’S LYMPHOMA (NHL) AND TARGETING WITH STRO-001, A NOVEL ANTI-CD74 ANTIBODY DRUG CONJUGATE (ADC) WITH POTENT IN VITROCYTOTOXICTY AND IN...

Science and Platform Publication Highlights

Presentations

Science and Platform Publication Highlights Biotechnol Bioeng. 2011 Jul;108(7):1570-8. doi: 10.1002/bit.23103. Epub 2011 Mar 31. Microscale to manufacturing scale-up of cell-free cytokine production–a new approach for shortening protein production development...

American Society of Hematology (ASH) 2017 – Oral Presentation

Presentations

American Society of Hematology (ASH) 2017 – Oral Presentation High Frequency of CD74 Expression in B-cell Non-Hodgkin’s Lymphoma (NHL) and Targeting with STRO-001, a Novel Anti-CD74 Antibody Drug Conjugate (ADC) with Potent In Vitro Cytotoxicity and In Vivo...

American Association for Cancer Research (AACR) 2017 – Poster

Presentations

American Association for Cancer Research (AACR) 2017 – Poster Characterization and pre-clinical development of STRO-001, a novel CD74-targeting antibody-drug conjugate (ADC) for the treatment of B-cell malignancies 2017 combined MM and NHL AACR...

American Society of Hematology (ASH) 2016 – NHL Oral Presentation

Presentations

American Society of Hematology (ASH) 2016 – NHL Oral Presentation Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin’s Lymphoma Arturo Molina, MD, MS Sutro Biopharma ASH Annual Meeting 2016 ASH NHL Oral...

American Society of Hematology (ASH) 2016 – Poster

Presentations

American Society of Hematology (ASH) 2016 – Poster Discovery and preclinical development of novel CD74-targeting antibody-drug conjugates (ADCs) with significant activity in multiple myeloma (MM) cell lines and xenograft models 2016 DEC ASH MM Poster final no...

« Older Entries

Next Entries »